Company intelligence / Profile preview

Delta Hat

Nottingham, UK

Ownership: Private
Employees: ~20
Development stage: Other

Overview

Delta Hat specialized in evidence-based value demonstration and advanced analytics (including health economic modeling and health technology assessment) for the pharmaceutical and life sciences sector. It was acquired by Petauri in June 2024 and merged with Mtech Access to form Petauri Evidence, offering more integrated global evidence and market access solutions for pharma, biotech, and medical device companies.

Industry: Consulting

Partnerships

Mtech Access (merged under Petauri Evidence)Petauri

Beyond the preview

Go deeper on Delta Hat.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Delta Hat.

Explore the full profile